首页> 外文期刊>International Journal of Pharmaceutics >Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa.
【24h】

Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa.

机译:理化和生物学参数对药物从囊和肠粘膜微球释放的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The object of our work is to develop mucoadhesive microspheres to be applied into the urinary bladder. In the present study the microspheres were prepared and the release of a model drug after their adhesion to mucosa was evaluated. The microspheres were prepared by solvent evaporation method using Eudragit RL or hydroxypropylcellulose as matrix polymers and one out of five different polymers as mucoadhesives or non-mucoadhesive references. A method for the evaluation of the drug release from microspheres adhered on guinea pig urinary bladder and small intestine mucosa was developed and the influence of the following parameters on this process was followed: mucoadhesion strength of polymeric films, swelling of polymers and the drug release from microspheres. The results showed that the detachment forces were decreasing in the following order: CMCNa > Carbopol 934P > HPC > EE.HCl = PVP/VA. Carbopol swelled to the largest volume among all polymers and the drug release from microspheres was more retarded when Eudragit RL was used as matrix polymer. When comparing the results of pipemidic acid release from microspheres adhered on intestinal mucosa with detachment forces, similar ratios among the mucoadhesive polymers can be seen. On the other hand, differences between two mucosae were observed. These differences are due to the amount of mucus on mucosa and might also be influenced by the charge of mucus. The goal of our work at this point of investigation was achieved by microspheres containing carboxymethylcellulose as mucoadhesive and Eudragit RL as matrix polymer because they provide the longest release time from microspheres adhered on vesical mucosa and sufficient high strength of mucoadhesion.
机译:我们工作的目的是开发将粘膜粘附性微球应用于膀胱。在本研究中,制备了微球并评估了模型药物与粘膜的粘附后的释放。通过溶剂蒸发法,使用Eudragit RL或羟丙基纤维素作为基质聚合物以及五种不同聚合物中的一种作为粘膜粘着剂或非粘膜粘着剂参考,制备微球。开发了一种评价粘附在豚鼠膀胱和小肠粘膜上的微球释放药物的方法,并遵循以下参数对该过程的影响:聚合物膜的粘膜粘附强度,聚合物溶胀和药物从膜中释放。微球。结果表明,剥离力按以下顺序减小:CMNCa> Carbopol 934P> HPC> EE.HCl = PVP / VA。当Eudragit RL用作基质聚合物时,Carbopol溶胀到所有聚合物中最大的体积,并且微球中的药物释放更加受阻。当比较从粘附在肠粘膜上的微球以剥离力释放哌啶酸的结果时,在粘膜粘附聚合物中的比率相似。另一方面,观察到两个粘膜之间的差异。这些差异是由于粘膜上粘液的数量所致,也可能受到粘液电荷的影响。我们的研究目标是通过含有羧甲基纤维素作为粘膜粘附剂和Eudragit RL作为基质聚合物的微球实现的,因为它们提供了从粘附在囊状粘膜上的微球释放时间最长和足够高的粘膜粘附强度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号